Access cutting-edge cystic fibrosis diabetes treatment through this clinical trial at a research site in Kansas City. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Kansas City location
Access cystic fibrosis diabetes specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cystic fibrosis diabetes treatment provided free
Check if you qualify for this cystic fibrosis diabetes clinical trial in Kansas City, MO
No-Cost Study Care
Local to Kansas City
Convenient for MO residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This multi-center randomized controlled trial (RCT) will compare efficacy and safety endpoints using the insulin-only configuration of the iLet Bionic Pancreas System (BP) versus a control group using their usual care insulin delivery method and continuous glucose monitoring (CGM) during a 13-week study period in individuals ≥14 years old with cystic fibrosis-related diabetes (CFRD). After 13 weeks, participants will continue in a 13-week Extension Phase in which the BP group will continue to us
Sponsor: Jaeb Center for Health Research
Yes, this clinical trial (NCT06449677) has an active research site in Kansas City, MO that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for cystic fibrosis diabetes treatment options in Kansas City, MO, this clinical trial (NCT06449677) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Kansas City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cystic fibrosis diabetes specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all cystic fibrosis diabetes clinical trials near you to find additional studies recruiting in your area.
See all essential tremor clinical trials recruiting in Kansas City — not just this study.
Browse Essential Tremor Trials in Kansas City →